Vegetarians have lower cardiovascular risk

A British study has shown that vegans have a 32% lower risk of suffering from vascular diseases. The trial that included 45,000 men and women stated that vegans also have lower risk of developing diabetes and lower MBI (max body index) which signals overweight and obesity. 

Results also show the importance of eating habits in preventing heart disease. Low cardiovascular risk for vegans results from a study carried out by a team of Oxford University, in Great Britain.

Researchers considered 44,561 men and women living in England and Scotland. From this population, 34 per cent had a vegan diet. After an 11 year follow up, it was determined that vegans have a 32% lower MI risk. This was independent from factors such as sex, age, obesity and others. This study was probably due to differences in cholesterol and arterial pressure. Vegans not only benefit from the positive impact of a lower BMI, but also benefit from a 28% heart disease risk reduction. 

Source

SOLACI.ORG

More articles by this author

Women Present Lower Risk of Sport Related Sudden Death Compared to Men

According to this recent analysis published in Eur Heart J, women would have a far lower chances of dying suddenly for physical exertion during...

Saturated Fats: Dietary Angels or Demons?

In order to reduce cardiovascular events, dietary guidelines recommend restricting saturated fatty acids—without taking into account differences among them—to <10% of the daily caloric...

Low-Carb Diet and Coronary Artery Calcium Progression

People on low carb diets since a young age present increased risk of coronary artery calcium progression, particularly when carbs are replaced by animal...

Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long-Term Predictors of Valve Deterioration After TAVI

Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe aortic valve stenosis. Initially implemented in elderly...

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...